Baker Avenue Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Baker Avenue Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,000	Closed	-$82K	–	258
2021 Q1	$82K	Hold	10,000	–	–	0.01%	240
2020 Q4	$68K	Hold	10,000	–	–	﹤0.01%	236
2020 Q3	$111K	Hold	10,000	–	–	0.01%	217
2020 Q2	$63K	Hold	10,000	–	–	0.01%	233
2020 Q1	$18K	Buy	+10,000	New	+$28.8K	﹤0.01%	195
2019 Q4	–	Sell	-10,000	Closed	-$21K	–	275
2019 Q3	$21K	Hold	10,000	–	–	﹤0.01%	238
2019 Q2	$26K	Hold	10,000	–	–	﹤0.01%	235
2019 Q1	$47K	Buy	+10,000	New	+$26.2K	﹤0.01%	242

Other funds holding SRNE

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return